Calcimedica

Developer of CRAC channel inhibitor drugs for inflammatory diseases

placeSan Diego, California, United States calendar_todayFounded 2006 groups11 employees language calcimedica.com

Registered entities

Investor mix

13 investors on record; lead investors include Valence Life Sciences, Sanderling Ventures, SR One, Biogen.

Investor typeCountShare
Venture capital1077%
Private equity18%
Other / undisclosed215%
Coming soon